↓ Skip to main content

PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial

Overview of attention for article published in BMC Cancer, March 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial
Published in
BMC Cancer, March 2022
DOI 10.1186/s12885-022-09283-z
Pubmed ID
Authors

Cynthia Ménard, Sympascho Young, Katherine Zukotynski, Robert J. Hamilton, François Bénard, Steven Yip, Christopher McCabe, Fred Saad, Michael Brundage, Roy Nitulescu, Glenn Bauman

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 18%
Student > Master 4 14%
Other 2 7%
Researcher 2 7%
Professor 1 4%
Other 2 7%
Unknown 12 43%
Readers by discipline Count As %
Medicine and Dentistry 10 36%
Nursing and Health Professions 2 7%
Biochemistry, Genetics and Molecular Biology 2 7%
Computer Science 1 4%
Agricultural and Biological Sciences 1 4%
Other 0 0%
Unknown 12 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2022.
All research outputs
#15,646,934
of 23,868,920 outputs
Outputs from BMC Cancer
#3,829
of 8,544 outputs
Outputs of similar age
#238,531
of 428,908 outputs
Outputs of similar age from BMC Cancer
#76
of 254 outputs
Altmetric has tracked 23,868,920 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,544 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 428,908 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 254 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.